SPATZ, M., HM. WOLF, Vojtěch THON, JM. GAMPFER and MM. EIBL. Immune response to the herpes simplex type 1 regulatory proteins ICP8 and VP16 in infected persons. JOURNAL OF MEDICAL VIROLOGY. 2000, vol. 62, No 1, p. 29-36. ISSN 0146-6615.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Immune response to the herpes simplex type 1 regulatory proteins ICP8 and VP16 in infected persons
Name in Czech Imunitní odpověď na regulační proteiny ICP8 and VP16 herpes simplex viru typu 1 u infikovaných osob
Authors SPATZ, M. (40 Austria), HM. WOLF (40 Austria), Vojtěch THON (203 Czech Republic, guarantor), JM. GAMPFER (276 Germany) and MM. EIBL (40 Austria).
Edition JOURNAL OF MEDICAL VIROLOGY, 2000, 0146-6615.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.289
RIV identification code RIV/00216224:14110/00:00035789
Organization unit Faculty of Medicine
UT WoS 000088492800005
Keywords (in Czech) herpes simplex virus
Keywords in English T CELL CLONES; PRIMARY GENITAL HERPES; NECROSIS FACTOR ALPHA; VIRUS TYPE 1; DENDRITIC CELLS; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; GENE EXPRESSION;
Tags ANTIBODY RESPONSE, antigen presentation, dendritic cells, GENE EXPRESSION, NECROSIS FACTOR ALPHA, PRIMARY GENITAL HERPES, T CELL CLONES, VIRUS TYPE 1
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Vojtěch Thon, Ph.D., učo 2483. Changed: 26/6/2009 00:14.
Abstract
The specific immune responses directed against the viral single stranded (ss) DNA binding protein ICP8 and the transactivator of immediate early (IE) gene expression VP16 (alpha-trans inducing factor, Vmw65) in HSV type 1 seropositive humans were examined. The results described in this paper indicate that neither ICP8 nor VP16 were able to induce a recall response in lymphocytes of healthy HSV seropositive individuals without recurrent infection, although CD4+ T cells purified from these individuals responded to both viral proteins in vitro when monocyte derived dendritic cells were used as antigen presenting cells. A recall response, however, could be induced to both viral proteins in T cells of patients with recurrent HSV infections when blood monocytes were used. Moreover, ICP8- and VP16-specific antibodies could be detected in the serum of patients with recurrent HSV infections whereas, in contrast, these antibodies were virtually absent in healthy HSV seropositive individuals without recurrences. These data represent the first systematic study of the immunological properties of ICP8 in humans, indicating a significant difference in the response to the essential viral regulators ICP8 and VP16 in HSV-1 seropositive healthy individuals as opposed to patients with recurrent HSV-1 infections.
Abstract (in Czech)
Imunitní odpověď na regulační proteiny ICP8 and VP16 herpes simplex viru typu 1 u infikovaných osob.
PrintDisplayed: 25/4/2024 19:11